Domain adaptation may be a novel creative solution to predict infection risk in patients with chronic lymphocytic leukemia ...

Researchers at Fondazione Policlinico Universitario Agostino Gemelli IRCCS have developed a promising machine learning algorithm capable of predicting survival and cause of death for patients with ...

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.

It is not always possible to prevent knee pain. But knowing about its risk factors, medications and home treatment can help ...

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a ...

Our joints rely on smooth, resilient cartilage and disc, which act as natural shock absorbers to enable painless movement. However, when these ...

A selective cytopheretic device for pediatrics demonstrated safety and potential benefit in 21 pediatric patients with life-threatening sepsis-associated AKI requiring kidney replacement therapy, ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

An estimated 2.8 million people worldwide are living with multiple sclerosis (MS), according to the National MS Society.

Blackstone Life Sciences will provide $400 million to support development of duvakitug, a human monoclonal antibody targeting ...

A new study published in JMIR Dermatology shows that TikTok has become a major source of education and support for people with skin of color living with hidradenitis suppurativa—a chronic, painful ...

Spotting the early signs of brain inflammation will save lives, experts have said in the wake of the death of a 12-year-old girl who took her own life while suffering from the effects of undiagnosed ...